NO20090926L - Fremgangsmate for a senke glukosenivaer - Google Patents
Fremgangsmate for a senke glukosenivaerInfo
- Publication number
- NO20090926L NO20090926L NO20090926A NO20090926A NO20090926L NO 20090926 L NO20090926 L NO 20090926L NO 20090926 A NO20090926 A NO 20090926A NO 20090926 A NO20090926 A NO 20090926A NO 20090926 L NO20090926 L NO 20090926L
- Authority
- NO
- Norway
- Prior art keywords
- glucose levels
- lowering glucose
- patient
- methods
- lowering
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 3
- 239000008103 glucose Substances 0.000 title abstract 3
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 abstract 1
- 229960003401 ramipril Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84085006P | 2006-08-28 | 2006-08-28 | |
| PCT/EP2007/007160 WO2008025450A1 (en) | 2006-08-28 | 2007-08-14 | Methods of lowering glucose levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090926L true NO20090926L (no) | 2009-03-27 |
Family
ID=38578487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090926A NO20090926L (no) | 2006-08-28 | 2009-02-27 | Fremgangsmate for a senke glukosenivaer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080188538A1 (enExample) |
| EP (1) | EP2059242A1 (enExample) |
| JP (1) | JP2010501604A (enExample) |
| KR (1) | KR20090042976A (enExample) |
| CN (1) | CN101573110A (enExample) |
| AU (1) | AU2007291602B2 (enExample) |
| BR (1) | BRPI0716411A2 (enExample) |
| CA (1) | CA2661598A1 (enExample) |
| IL (1) | IL197189A0 (enExample) |
| MX (1) | MX2009002091A (enExample) |
| NO (1) | NO20090926L (enExample) |
| WO (1) | WO2008025450A1 (enExample) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA817261B (en) * | 1980-10-23 | 1982-09-29 | Schering Corp | Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them |
| DE3226768A1 (de) * | 1981-11-05 | 1983-05-26 | Hoechst Ag, 6230 Frankfurt | Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung |
| DE3413710A1 (de) * | 1984-04-12 | 1985-10-24 | Hoechst Ag, 6230 Frankfurt | Verfahren zur behandlung der herzinsuffizienz |
| DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
| CA2026686A1 (en) * | 1989-10-30 | 1991-05-01 | Werner Tschollar | Method for preventing onset of type ii diabetes employing an ace inhibitor |
| SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| DK1216038T3 (da) * | 1999-08-30 | 2005-12-27 | Sanofi Aventis Deutschland | Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser |
| WO2003032965A2 (en) * | 2001-10-17 | 2003-04-24 | King Pharmaceuticals Research And Development, Inc | Use of ace inhibitors for reducing type 2 diabetes in high risk patients |
| US20050065203A1 (en) * | 2001-10-17 | 2005-03-24 | Salim Yusuf | Method of reducing type 2 diabetes in high risk patients |
| CA2458288A1 (en) * | 2003-03-11 | 2004-09-11 | Institut De Cardiologie De Montreal / Montreal Heart Institute | Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
-
2007
- 2007-08-14 CA CA002661598A patent/CA2661598A1/en not_active Abandoned
- 2007-08-14 EP EP07786675A patent/EP2059242A1/en not_active Withdrawn
- 2007-08-14 KR KR1020097005581A patent/KR20090042976A/ko not_active Ceased
- 2007-08-14 WO PCT/EP2007/007160 patent/WO2008025450A1/en not_active Ceased
- 2007-08-14 BR BRPI0716411-4A2A patent/BRPI0716411A2/pt not_active IP Right Cessation
- 2007-08-14 MX MX2009002091A patent/MX2009002091A/es not_active Application Discontinuation
- 2007-08-14 AU AU2007291602A patent/AU2007291602B2/en not_active Ceased
- 2007-08-14 JP JP2009525948A patent/JP2010501604A/ja active Pending
- 2007-08-14 CN CNA2007800400375A patent/CN101573110A/zh active Pending
- 2007-08-28 US US11/846,310 patent/US20080188538A1/en not_active Abandoned
-
2009
- 2009-02-23 IL IL197189A patent/IL197189A0/en unknown
- 2009-02-27 NO NO20090926A patent/NO20090926L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL197189A0 (en) | 2009-12-24 |
| JP2010501604A (ja) | 2010-01-21 |
| AU2007291602A1 (en) | 2008-03-06 |
| CA2661598A1 (en) | 2008-03-06 |
| AU2007291602B2 (en) | 2012-09-06 |
| US20080188538A1 (en) | 2008-08-07 |
| MX2009002091A (es) | 2009-03-09 |
| EP2059242A1 (en) | 2009-05-20 |
| CN101573110A (zh) | 2009-11-04 |
| KR20090042976A (ko) | 2009-05-04 |
| WO2008025450A1 (en) | 2008-03-06 |
| BRPI0716411A2 (pt) | 2013-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083863L (no) | Pyrazoler som 11-beta-hsd-1 | |
| EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
| NO20090590L (no) | Metabolisme modulatorer samt behandling av lidelser relatert dertil | |
| EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
| NO20044562L (no) | Fremgangsmater for behandling av tarmslyng | |
| WO2008039829A3 (en) | Diphenylheterocycle cholesterol absorption inhibitors | |
| NO20070910L (no) | Pyrrolderivater som farmasoytiske middel | |
| EA201100266A1 (ru) | Диокса-бицикло[3.2.1]октан-2,3,4-триольные производные | |
| CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
| EA201071144A1 (ru) | Гетероциклические производные | |
| ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
| NO20090173L (no) | Kondensert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes | |
| MX2009009416A (es) | Derivados de bencimidazol y sus metodos de uso. | |
| WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
| EA200900091A1 (ru) | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний | |
| ATE506340T1 (de) | 12-aryl-prostaglandin-analoga | |
| WO2007143607A3 (en) | Method of treating atrophic vaginitis | |
| NO20084826L (no) | Ny administrasjonsform av racecadotril | |
| EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
| NO20083836L (no) | N-hydroksyakrylamidforbindelser | |
| WO2007106884A3 (en) | Methods of treating muscular wasting diseases using nf-kb activation inhibitors | |
| TW200801032A (en) | Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders | |
| WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
| BRPI0716643A2 (pt) | amidas terapêuticas e compostos relacionados | |
| EA201000391A1 (ru) | Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |